Cargando…
Tetrahydrobiopterin (BH(4)) Supplementation Prevents the Cardiorenal Effects of Diabetes in Mice by Reducing Oxidative Stress, Inflammation and Fibrosis
Background: The effects of diabetes on the cardiovascular system as well as in the kidney are profound, which include hypertrophy and fibrosis. Diabetes also induces oxidative stress, at least in part due to the uncoupling of nitric oxide synthase (NOS); this is a shift in NO production toward super...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599239/ https://www.ncbi.nlm.nih.gov/pubmed/36289741 http://dx.doi.org/10.3390/biomedicines10102479 |
_version_ | 1784816546976104448 |
---|---|
author | Novoa, Ulises Soto, Karen Valdés, Cristian Villaseñor, Jorge Treuer, Adriana V. González, Daniel R. |
author_facet | Novoa, Ulises Soto, Karen Valdés, Cristian Villaseñor, Jorge Treuer, Adriana V. González, Daniel R. |
author_sort | Novoa, Ulises |
collection | PubMed |
description | Background: The effects of diabetes on the cardiovascular system as well as in the kidney are profound, which include hypertrophy and fibrosis. Diabetes also induces oxidative stress, at least in part due to the uncoupling of nitric oxide synthase (NOS); this is a shift in NO production toward superoxide production due to reduced levels of the NOS cofactor tetrahydrobiopterin (BH(4)). With this in mind, we tested the hypothesis that BH(4) supplementation may prevent the development of diabetic cardiomyopathy and nephropathy. Methods: Diabetes was induced in Balb/c mice with streptozotocin. Then, diabetic mice were divided into two groups: one group provided with BH(4) (sapropterin) in drinking water (daily doses of 15 mg/kg/day, during eight weeks) and the other that received only water. A third group of normoglycemic mice that received only water were used as the control. Results: Cardiac levels of BH(4) were increased in mice treated with BH(4) (p = 0.0019). Diabetes induced cardiac hypertrophy, which was prevented in the group that received BH(4) (p < 0.05). In addition, hypertrophy was evaluated as cardiomyocyte cross-sectional area. This was reduced in diabetic mice that received BH(4) (p = 0.0012). Diabetes induced cardiac interstitial fibrosis that was reduced in mice that received BH(4) treatment (p < 0.05). We also evaluated in the kidney the impact of BH(4) treatment on glomerular morphology. Diabetes induced glomerular hypertrophy compared with normoglycemic mice and was prevented by BH(4) treatment. In addition, diabetic mice presented glomerular fibrosis, which was prevented in mice that received BH(4). Conclusions: These results suggest that chronic treatment with BH(4) in mice ameliorates the cardiorenal effects of diabetes,(,) probably by restoring the nitroso–redox balance. This offers a possible new alternative to explore a BH(4)-based treatment for the organ damage caused by diabetes. |
format | Online Article Text |
id | pubmed-9599239 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-95992392022-10-27 Tetrahydrobiopterin (BH(4)) Supplementation Prevents the Cardiorenal Effects of Diabetes in Mice by Reducing Oxidative Stress, Inflammation and Fibrosis Novoa, Ulises Soto, Karen Valdés, Cristian Villaseñor, Jorge Treuer, Adriana V. González, Daniel R. Biomedicines Article Background: The effects of diabetes on the cardiovascular system as well as in the kidney are profound, which include hypertrophy and fibrosis. Diabetes also induces oxidative stress, at least in part due to the uncoupling of nitric oxide synthase (NOS); this is a shift in NO production toward superoxide production due to reduced levels of the NOS cofactor tetrahydrobiopterin (BH(4)). With this in mind, we tested the hypothesis that BH(4) supplementation may prevent the development of diabetic cardiomyopathy and nephropathy. Methods: Diabetes was induced in Balb/c mice with streptozotocin. Then, diabetic mice were divided into two groups: one group provided with BH(4) (sapropterin) in drinking water (daily doses of 15 mg/kg/day, during eight weeks) and the other that received only water. A third group of normoglycemic mice that received only water were used as the control. Results: Cardiac levels of BH(4) were increased in mice treated with BH(4) (p = 0.0019). Diabetes induced cardiac hypertrophy, which was prevented in the group that received BH(4) (p < 0.05). In addition, hypertrophy was evaluated as cardiomyocyte cross-sectional area. This was reduced in diabetic mice that received BH(4) (p = 0.0012). Diabetes induced cardiac interstitial fibrosis that was reduced in mice that received BH(4) treatment (p < 0.05). We also evaluated in the kidney the impact of BH(4) treatment on glomerular morphology. Diabetes induced glomerular hypertrophy compared with normoglycemic mice and was prevented by BH(4) treatment. In addition, diabetic mice presented glomerular fibrosis, which was prevented in mice that received BH(4). Conclusions: These results suggest that chronic treatment with BH(4) in mice ameliorates the cardiorenal effects of diabetes,(,) probably by restoring the nitroso–redox balance. This offers a possible new alternative to explore a BH(4)-based treatment for the organ damage caused by diabetes. MDPI 2022-10-04 /pmc/articles/PMC9599239/ /pubmed/36289741 http://dx.doi.org/10.3390/biomedicines10102479 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Novoa, Ulises Soto, Karen Valdés, Cristian Villaseñor, Jorge Treuer, Adriana V. González, Daniel R. Tetrahydrobiopterin (BH(4)) Supplementation Prevents the Cardiorenal Effects of Diabetes in Mice by Reducing Oxidative Stress, Inflammation and Fibrosis |
title | Tetrahydrobiopterin (BH(4)) Supplementation Prevents the Cardiorenal Effects of Diabetes in Mice by Reducing Oxidative Stress, Inflammation and Fibrosis |
title_full | Tetrahydrobiopterin (BH(4)) Supplementation Prevents the Cardiorenal Effects of Diabetes in Mice by Reducing Oxidative Stress, Inflammation and Fibrosis |
title_fullStr | Tetrahydrobiopterin (BH(4)) Supplementation Prevents the Cardiorenal Effects of Diabetes in Mice by Reducing Oxidative Stress, Inflammation and Fibrosis |
title_full_unstemmed | Tetrahydrobiopterin (BH(4)) Supplementation Prevents the Cardiorenal Effects of Diabetes in Mice by Reducing Oxidative Stress, Inflammation and Fibrosis |
title_short | Tetrahydrobiopterin (BH(4)) Supplementation Prevents the Cardiorenal Effects of Diabetes in Mice by Reducing Oxidative Stress, Inflammation and Fibrosis |
title_sort | tetrahydrobiopterin (bh(4)) supplementation prevents the cardiorenal effects of diabetes in mice by reducing oxidative stress, inflammation and fibrosis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599239/ https://www.ncbi.nlm.nih.gov/pubmed/36289741 http://dx.doi.org/10.3390/biomedicines10102479 |
work_keys_str_mv | AT novoaulises tetrahydrobiopterinbh4supplementationpreventsthecardiorenaleffectsofdiabetesinmicebyreducingoxidativestressinflammationandfibrosis AT sotokaren tetrahydrobiopterinbh4supplementationpreventsthecardiorenaleffectsofdiabetesinmicebyreducingoxidativestressinflammationandfibrosis AT valdescristian tetrahydrobiopterinbh4supplementationpreventsthecardiorenaleffectsofdiabetesinmicebyreducingoxidativestressinflammationandfibrosis AT villasenorjorge tetrahydrobiopterinbh4supplementationpreventsthecardiorenaleffectsofdiabetesinmicebyreducingoxidativestressinflammationandfibrosis AT treueradrianav tetrahydrobiopterinbh4supplementationpreventsthecardiorenaleffectsofdiabetesinmicebyreducingoxidativestressinflammationandfibrosis AT gonzalezdanielr tetrahydrobiopterinbh4supplementationpreventsthecardiorenaleffectsofdiabetesinmicebyreducingoxidativestressinflammationandfibrosis |